Volume 72, Issue 1, Pages (July 2017)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Volume 72, Issue 3, Pages (September 2017)
Early Detection of Prostate Cancer in 2007
Volume 55, Issue 1, Pages 1-8 (January 2009)
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 2, Pages (August 2017)
Volume 57, Issue 1, Pages (January 2010)
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 73, Issue 3, Pages (March 2018)
European Urology Focus
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Mapping of Pelvic Lymph Node Metastases in Prostate Cancer
Volume 70, Issue 1, Pages (July 2016)
Volume 67, Issue 4, Pages (April 2015)
Volume 63, Issue 1, Pages (January 2013)
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 66, Issue 3, Pages (September 2014)
Volume 58, Issue 5, Pages (November 2010)
Volume 70, Issue 6, Pages (December 2016)
Volume 73, Issue 3, Pages (March 2018)
Volume 73, Issue 1, Pages (January 2018)
Volume 61, Issue 2, Pages (February 2012)
Prostate Cancer Epidemic in Sight?
Treatment of Nightmares With Prazosin: A Systematic Review
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration- resistant Prostate Cancer in the Era of Precision Oncology  Philipp.
Volume 65, Issue 6, Pages (June 2014)
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Volume 61, Issue 1, Pages (January 2012)
Volume 73, Issue 3, Pages (March 2018)
Volume 68, Issue 4, Pages (October 2015)
Volume 54, Issue 4, Pages (October 2008)
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
Volume 71, Issue 3, Pages (March 2017)
Volume 70, Issue 3, Pages (September 2016)
Volume 74, Issue 2, Pages (August 2018)
Volume 68, Issue 3, Pages (September 2015)
Volume 64, Issue 5, Pages (November 2013)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 4, Pages (April 2016)
Volume 66, Issue 6, Pages (December 2014)
Volume 70, Issue 5, Pages (November 2016)
Volume 73, Issue 2, Pages (February 2018)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Yuanshan Cui, Yong Zhang  European Urology 
Volume 72, Issue 5, Pages (November 2017)
Volume 71, Issue 4, Pages (April 2017)
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer  I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,
Volume 58, Issue 1, Pages 1-7 (July 2010)
Volume 73, Issue 3, Pages (March 2018)
Volume 62, Issue 6, Pages (December 2012)
Volume 72, Issue 2, Pages (August 2017)
Volume 72, Issue 6, Pages (December 2017)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 74, Issue 6, Pages (December 2018)
Volume 73, Issue 2, Pages (February 2018)
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
European Urology Oncology
Volume 71, Issue 3, Pages (March 2017)
Measuring non-technical skills of anaesthesiologists in the operating room: a systematic review of assessment tools and their measurement properties 
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Volume 52, Issue 6, Pages (December 2007)
Systematic Review of Complications of Prostate Biopsy
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 72, Issue 1, Pages 84-109 (July 2017) The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review  Nicola Fossati, Peter-Paul M. Willemse, Thomas Van den Broeck, Roderick C.N. van den Bergh, Cathy Yuhong Yuan, Erik Briers, Joaquim Bellmunt, Michel Bolla, Philip Cornford, Maria De Santis, Ekelechi MacPepple, Ann M. Henry, Malcolm D. Mason, Vsevolod B. Matveev, Henk G. van der Poel, Theo H. van der Kwast, Olivier Rouvière, Ivo G. Schoots, Thomas Wiegel, Thomas B. Lam, Nicolas Mottet, Steven Joniau  European Urology  Volume 72, Issue 1, Pages 84-109 (July 2017) DOI: 10.1016/j.eururo.2016.12.003 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Anatomical areas for the definition of the extent of dissection. I=obturator nodes; II=external iliac nodes; III=internal iliac nodes; IV=common iliac nodes; V=presacral nodes. European Urology 2017 72, 84-109DOI: (10.1016/j.eururo.2016.12.003) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 2 Study selection flow diagram according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. European Urology 2017 72, 84-109DOI: (10.1016/j.eururo.2016.12.003) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 3 Risk of bias assessment for individual studies. (A) Oncological outcomes. (B) Non-oncological outcomes. NRS=nonrandomized study; RCT=randomized clinical trial. European Urology 2017 72, 84-109DOI: (10.1016/j.eururo.2016.12.003) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 3 Risk of bias assessment for individual studies. (A) Oncological outcomes. (B) Non-oncological outcomes. NRS=nonrandomized study; RCT=randomized clinical trial. European Urology 2017 72, 84-109DOI: (10.1016/j.eururo.2016.12.003) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 4 Risk of bias assessment across included studies. (A) Oncological outcomes. (B) Non-oncological outcomes. BMI=body mass index; pGS=pathological Gleason score. European Urology 2017 72, 84-109DOI: (10.1016/j.eururo.2016.12.003) Copyright © 2016 European Association of Urology Terms and Conditions